Here are six highlights:
1. Mr. Koblish has 25 years of medical device experience and has served on Cerapedics’ board of directors since 2013.
2. Mr. Koblish co-founded and serves as president and CEO of TELA Bio, a biosurgical reconstruction company.
3. He previously was president and CEO of Orthovita, where he oversaw its sale to Stryker for $316 milion.
4. The company also appointed Doug Kohrs to its board of directors.
5. Mr. Kohrs has served in various roles during his 35-year career in the medical device industry, including a founder, board member and executive. He currently is the managing director of Responsive Arthroscopy.
6. Mr. Kohrs founded Responsive Orthopedics, which Medtronic acquired in 2016.
More articles on biologics:
US regenerative medicine market to see 33% CAGR boost through 2022— 4 observations
Smith & Nephew to purchase regenerative medicine company for $210M: 3 points
Anika Therapeutics appoints new chief human resources officer: 5 points
